Serum prolactin concentrations in benign breast disease throughout the menstrual cycle
- PMID: 880967
- DOI: 10.1016/0014-2964(77)90122-0
Serum prolactin concentrations in benign breast disease throughout the menstrual cycle
Similar articles
-
Serum oestradiol-17 beta in women with benign and malignant breast disease.Br J Cancer. 1974 Dec;30(6):571-6. doi: 10.1038/bjc.1974.237. Br J Cancer. 1974. PMID: 4447785 Free PMC article.
-
Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.Clin Oncol. 1981 Sep;7(3):213-9. Clin Oncol. 1981. PMID: 6211319 No abstract available.
-
[Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].Nouv Presse Med. 1974 Jan 12;3(2):73-5. Nouv Presse Med. 1974. PMID: 4815434 French. No abstract available.
-
Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.Br J Cancer. 1974 Aug;30(2):176-7. doi: 10.1038/bjc.1974.144. Br J Cancer. 1974. PMID: 4419442 Free PMC article. No abstract available.
-
Proceedings: Prolactin in benign and malignant breast disease.J Endocrinol. 1976 Jun;69(3):49P-50P. J Endocrinol. 1976. PMID: 950543 No abstract available.
Cited by
-
Pharmacology of bromocriptine in health and disease.Drugs. 1979 May;17(5):313-25. doi: 10.2165/00003495-197917050-00001. Drugs. 1979. PMID: 222567 Review.
-
Effect of human, bovine and ovine prolactin on DNA synthesis by organ cultures of benign human breast tumours.Br J Cancer. 1979 Dec;40(6):866-71. doi: 10.1038/bjc.1979.278. Br J Cancer. 1979. PMID: 575047 Free PMC article.
-
Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.J Endocrinol Invest. 1988 Oct;11(9):679-83. doi: 10.1007/BF03350214. J Endocrinol Invest. 1988. PMID: 2975693
-
Therapeutic applications of bromocriptine in endocrine and neurological diseases.Drugs. 1988 Jul;36(1):67-82. doi: 10.2165/00003495-198836010-00005. Drugs. 1988. PMID: 3063495 Review.
-
Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):463-98. doi: 10.1007/BF03259897. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063922 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources